Animal Cell Technology Meets Genomics
Godia, Francesc
Venduto da moluna, Greven, Germania
Venditore AbeBooks dal 9 luglio 2020
Nuovi - Rilegato
Condizione: Nuovo
Spedito da Germania a U.S.A.
Quantità: Più di 20 disponibili
Aggiungere al carrelloVenduto da moluna, Greven, Germania
Venditore AbeBooks dal 9 luglio 2020
Condizione: Nuovo
Quantità: Più di 20 disponibili
Aggiungere al carrelloThe 18th ESACT meeting was celebrated in Granada (Spain) in May 2003, and was entitled Animal Cell Technology Meets Genomics , in order to reflect that the emerging technologies in the area of genomics, proteomics and other -omics -type disc.
Codice articolo 67161300
Meeting Committees; ESACT Executive Committee; Sponsors; Companies Participating in the Trade Exhibition; Introduction: Animal Cell Technology Meets Genomics; Acknowledgements; List of Participants; CHAPTER 1: CELLULAR MECHANISMS; Effect of osmotic pressure on GS-NSO expression system, Wu M., et at.; Molecular approaches to influence epigenetic effectors of transient and stable transgene expression in mammalian cells, Hacker D. et al.; Genomic exploration on Chinese hamster ovary cells, de Leon Gatti M. et al.; Roles for glycosylation in receptor-ligand interactions in the immune system, Rudd, P.M. et al.; Investigations on mannose-6-phosphate receptor mediated protein uptake, Duerrschmid M., Jursik, et al.; Analysis of multiple apoptosis parameters using a microfluidic chip-based system, Valer M. et al.; Inhibiting apoptosis in cell culture using multiple inhibitors, Figueroa, B. et al.; Pausing of mammalian cells by cold exposure, limits and Opportunities, Hunt L. et al.; The functional competence of animal cells: analysis of the secretory pathway, Racher A.J. et al.; Proteome analysis of recombinant CHO cells under hyperosmotic stress, Lee M.S. et al.; Expression profiling analysis of sodium butyrate-induced Chinese hamster ovary cells in defined medium, Melville M.W. et al.; Intracellular nucleotide pools for optimizing productoriented transient transfection of HEK293 cells in suspension, Bassani Molinas M.M. et al.; Impact of yeast pyruvate carboxylase on the productivity of animal host cell lines, Bollati Fogolín M. et al.; Environmental effects of lactate on High-Five™ insect cell Metabolism, Drugmand J.-C. et al.; Correlation of intracellular nucleotide pools to amino acid concentrations in culture media by the application of multivariate methods, Hesse F. et al.; Engineering Trichoplusia ni (High Five™) insect cells to express a cytosolic pyruvate carboxlase enzyme improves the viability of the cells in batch, fed-batch and perfusion cultures, Locas M.-C. et al.; Insect cell culture medium selection and optimisation based on monitoring and economical considerations, Lecina M. et al.; Antiapoptotic activity of synthetic and natural peptides, Franek F. et al.; Effect of antiapoptotic genes expression on cell growth and monoclonal antibody productivity in a hybridoma cell line, Juanola S. et al.; Amplified dicistronic expression units mediate apoptosis protection in CHO-DG44 cells adapted for growth in serum-free media, impact on mitochondria copy number, Meents H. et al.; Effect of reduced water on the apoptotic cell death triggered by oxidative stress in pancreatic ß HIT-T15 cell, Shirahata S. et al.; Characterization of apoptosis in a CHO cell line cultivated in batch and continuous culture: Effect of medium, specific perfusion rate and chemical inhibitors, Thrift J. et al.; Hydrogen peroxide-induced cellular senescence is regulated via two different pathways, Yoshizaki K. et al.; Identification of autocrine factors influencing proliferation in serum free cultures of Trichoplusia ni cells, Eriksson U. et al.; The effects of insulin and Long™R3IGF-I on Chinese hamster ovary cells: cell survival, receptor activation and second messenger pathways. Yandell C.A. et al.; Conditioned medium factors in protein-free cultures of NS0 cells, Spens E. et al.; Production of human anti-peptide antibody for clinical use by in vitro immunization, Tamura, T. et al.; Optimization of in vitro immunization protocol to produce antigen specific human monoclonal antibody by demonstrating the role of IL-10, Xu Q.H. et al.; Extracellular histone H4 from SF9 cells is antimicrobial, Calles K. et al.; Analyzing calcium phosphate transfection of adherent CHO cells using microscopic live imaging, Grosjean F. et al.; Effects of multiplicity of infection (MOI) and cell cycle on Baculovirus infection kinetics, Haas R. et al.; Non-freezing preservation and subsequent recovery of hepatocytes under pO2- and pH-controlled conditions for continuous supply of cells for bioartificial liver support, Iding K. et al.; Selection of MDCK subclones with various genotypic and phenotypic markers: sensitivity to influenza virus infection, Kessler N. et al.; Extracellular metalloproteases and their inhibitors expressed by the IFN-ã producing CHO-320 cell line, Mols J. et al.; Novel small-molecule AKT1 inhibitors discovered by Redistribution™-based high-throughput screening. Præstegaard M. et al.; Influence of mistletoe extracts and its components on invitro physiology of cancer cells, Sidler F. et al.; Rapid in-process monitoring of antibody integrity, purity and titre-2100 Bioanalyser (Lab on a chip) study, Nesredin A. et al.; Toxicological evaluation of haine river waste-water samples to appropriately sensitised cultured Fathead Minnow cells compared with the microtox® method, Dierickx P.J. et al.; CHAPTER 2: CELL BASED THERAPIES; 3D-cultivation and characterisation of osteogenic cells for the production of highly viable bone tissue implants, Barthold M. et al.; Carbon source has a considerable influence on extracellular matrix formation, demonstrated on specific collagen expression of primary human tenocytes, Möbest D. et al.; Design and characterization of cardiomyocyte-derived micro issues, Kelm M.J. et al.; Process development for standardized generation of monocyte-derived dendritic cells: applicability in breast cancer immunotherapy, Bohnenkamp H.R. et al.; Stemline™ hematopoietic stem cell expansion medium, a serum-free medium for expansion of CD34+ hematopoietic stem cells and progenitors, Leugers S. et al.; Mesenchymal stem cells: a very first step towards large scale cell culture strategies transplantation, Bensellam M. et al.; Expansion of murine embryonic stem cells on microcarriers-functional characteristics and scale-up potential, Burg M. et al.; In vitro cultivation of rabbit mesenchymal stromal cells on 3D bioresorbable calcium phosphate scaffolds for the generation of bone tissue implants, Fargali S. et al.; Establishment and characterization of human medullary thyroid carcinoma cell lines for immunotherapy, Stradler G. et al.; Suppression of cell growth by platinum nanocolloids as scavengers against reactive oxygen species, Hamasaki T. et al.; Comparison of fluidized bed and fed batch reactor cultures for production of anti-HIV-antibody, Hinterleitner P. et al.; Suppression of oxidative stress-induced apoptosis of neuronal cells by electrolyzed-reduced water, Kashiwagi T. et al.; Spheroid formation by encapsulation of cancer cells to mimic small size tumors, Marc A. et al.; Bioreactor for continuous biomechanical characterization of cellular systems and tissue-engineered biohybrid tissues, Möbest D. et al.; Membrane-separated cocultivation of cord blood hematopoietic stem cells with stromal cell lines, Fischbach T. et al.; Anti-apoptotic genes protect an insulinoma cell line from cell death induced by hyperglycemia, Ogawa A. et al.; Preparation and characterization of an idiotype-dendritic cell vaccine for immunotherapy of multiple myeloma, Opalka B. et al.; Pretreatment with polycations enhances Adenoviral infection levels in serum-free PER.C6™ cells as well as HEK 293 cells, Padilla J. et al.; Optimizing the production of cardiomyocytes from mouse embryonic stem cells in a 2L stirred tank reactor, Schroeder M. et al.; Establishment and characterization of CD4+ Killer-T-Cells (KTCs), Voglauer R. et al.; CHAPTER 3: GENE BASED THERAPEUTICS; Successful development of a robust adenovirus production process primarily relies on a better understanding of packaging cell line physiology and vector replication kinetics, Kamen A. et al.; Retroviral vector stability: inactivation kinetics and membrane properties, Cruz P. et al.; Comparison of host cell lines and production methods for a new generation of oncolytic adenoviral vectors, Forestell S. et al.; Process development for a veterinary vaccine against heartwater, Marcelino I. et al.; A new method for the quantitative determination of enveloped viral particles, Beer C. et al.; Development of a 293T cell line for the production of virus like particles in bioreactors, Costa M.J.L. et al.; Effect of MOI and medium composition on adenovirus infection kinetics, Ferreira T. et al.; ION-exchange chromatography based strategies for purification of viral vectors, Vasi J. et al.; Scaling up of endothelial cells culture for the production of a rickettsiae vaccine: evaluation of the importance of the interference effects, Hendrick V. et al.; CHAPTER 4: TARGET DISCOVERY; Inducible gene expression for antibiotic drug discovery and diagnostics Weber W. et al.; Nucleic acid capture assay: a novel high-throughput method for direct mRNA quantitation Van de Goor J. et al.; High throughput transient transfections of HEK293EBNA cells: development of an integrated expression purification process at 100 ml scale, Heine H., Rey L. et al.; Transient gene expression in suspension HEK293 cells: application to large-scale protein production, Baldi L., Jacquet R. et al.; Monoclonal antibody production: determination of appropriate system and medium for production enhancement and decrease of overall production time, Fritchman K. et al.; The secrets of transfection in serum-free suspension culture Geisse S. et al.; From genes to proteins: full open reading frame (ORF) clones and their application in functional research, Goedde A. et al.; A versatile disposable culture system for high throughput screening of process parameters and production cell lines, Jordan M. et al.; Long time storage of pre-inoculated multi-well plates for cell-based assay kits used for drug identification and characterization, Loa A. et al.; Comparative secretion levels of recombinant proteins between insect cell-baculovirus and mammalian HEK293EBNA cells, Losberger C. et al.; Microfluidic technology applied to protein sizing and Quantitation, Valer M. et al.; CryoStock – a software for cell culture management, Zerlin M. et al.; CHAPTER 5: BIOPHARMACEUTICALS; Targeting the human Immunoglobulin loci for high level heterologous gene expression, Winkler K. et al.; MAR elements as tools to increase protein production by CHO cells, Girod, P.-A. et al.; Cell line engineering for production of therapeutic antibody glycoforms with increased biological activity, Umana P. et al.; Development of a metabolically optimized fermentation process based on glucose-limited CHO perfusion culture; Applications of quasi real-time metabolic flux analysis in mammalian cell culture process, Goudar C. et al.; Data-based modelling of cell cultures, Cunha-Bakeev C. et al.; Cell culture and downstream processing integration using ProteinChip® technology. Application to protein analysis and purification in biopharmaceutical manufacturing, Bengio S. et al.; The prospects for insect cells for use as a cell substrate for the production of biotherapeutics, Galbraith D.N.; High-performance cell culture platform technology for Mab production, Chang D.Y.H. et al.; Development and integration of a new animalcomponent-free process for the production of UK- 279,276, Pluschkell S. et al.; Towards an affinity-based capture system for the isolation of high expression cells using a co-expressed surface protein, Derouazi M. et al.; Effect of doxycycline-regulated calnexin and calreticulin expression on specific thrombopoietin productivity of recombinant CHO cells, Chung J.Y. et al.; Recombinant glycoprotein expression. Development of a homologous CHO expression system, Noone C. et al.; Generation of recombinant antibody manufacturing cell lines using cell-cell fusion, Zeng W. et al.; Cloning and expression of biopharmaceuticals in CHO.K1 and BHK-21 cells, Castilho L.R. et al.; Camel single-domain antibodies as modular building blocks to make bivalent constructs for use in immunotheraphy of cancer, Cortez-Retamozo V. et al.; Establishment of efficient cloning method for variable region genes of antigen specific human monoclonal antibody, Matsumoto S. et al.; From gene to monoclonal antibody: efficient screening by cell sorting, Borth N. et al.; Development of an integrated strategy for recombinant cell line selection, Castillo A.J. et al.; Gene transfer to animal cells in culture by microinjection: A novel tool to create recombinant cell lines? Derouazi M. et al.; Evaluation of the stability of NS0 cell lines expressing recombinant human IgG, Forrest-Owen W. et al.; High throughput screening and selection of single cells in suspension using fluorescence parameters, Giese C. et al.; Control of key parameters in the development of mammalian production clones Kunert R. et al.; Establishment of screening systems for recombinant cell lines: early prediction of the suitability as a production clone, Lattenmayer C. et al.; Characterisation of CHO subclones showing profound changes in performance when propagated in different cultivation systems, Trummer E. et al.; High level production of recombinant IgG in the human cell line PER.C6™, Yallop C. et al.; Creating a new medium to help meet the variable nutritional requirements of Chinese hamster ovary (CHO) cell clones, Deeds Z.W. et al.; Development of an efficient medium optimization kit for factorial matrix design - a statistical approach to increase cell growth and productivity of recombinant CHO cells, Delong B. et al.; An efficient approach to cell culture medium optimization – a statistical method to medium mixing, Gifford J. et al.; Virus inactivation in foetal calf serum by a combined, treatment of gamma-irradiation and UV-C irradiation, Hermann H. et al.; Advances in media optimization: two automated approaches that increase expression while reducing development time, Holdread S. et al.; The importance of cholesterol for insect cell growth and baculovirus production, Lua L.H.L. et al.; Use of rapeseed proteins and peptides as supplements in insect cell cultures, Marc A. et al.; Nutritional performance of wheat gluten -derived protein hydrolysates in hybridoma cell cultures, Martens D.E. et al.; SyntheChol™ synthetic cholesterol for cholesterol dependent cell culture. Development of non-animal derived chemically defined NS0 medium, Talley D. et al.; NS0 derivatives: MAb production in large-scale SFM formats, Manwaring J. et al.; Silk protein sericin accelerates proliferation of various mammalian cells, Terada S. et al.; Image analysis based realtime-control of glucose concentration, Brueckerhoff T. et al.; On line analysis of microcarrier cultivations, Burzlaff A. et al.; Error analysis during estimation of metabolic fluxes through metabolite balancing, Goudar C. et al.; Generalized logistic equation modeling of mammalian cell batch cultures, Goudar C. et al.; In-situ microscopy based monitoring of mammalian cell culture processes, Joeris K. et al.; A novel disposable microtube for rapid assessment of biomass in cell cultures, Jordan M.; Intracellular monitoring of baculovirus infection of Sf9 insect cells and r-protein production using anti-alpha-1,3/4 fucosyltransferase antibodies and flow cytometry, Marc A. et al.; Effect of glucose and glutamine concentration on metabolism of animal cells in chemostat culture, Matsuoka H. et al.; Evaluation of a novel capacitance probe for on-line monitoring of viable cell densities in batch and fedbatch animal cell culture processes, Schmid G. et al.; Sodium butyrate enhancement of protein expression in HeLa cells: follow-up of a chimeric reporter gene behaviour for process development, Bassens C. et al.; Scalable, serum-free, high efficiency transfection of CHO Cells using an economical DNA transfer vehicle, Girard P. et al.; Process optimization for an NS0-derived hybridoma cell line in a chemically defined, protein-free medium, Johnson J.M. et al.; Impact of change in fermentation process pH and dissolved carbon dioxide concentration on secreted antibody structure and cell physiology of a GS-NS0 cell line expressing a human antibody,...
Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.
Visita la pagina della libreria
Avviso di revoca/
Condizioni Generali di Contratto e informazioni per i clienti/
Informativa sulla privacy
Diritto di recesso per consumatori
(Il consumatore è qualsiasi persona fisica che conclude un negozio giuridico per scopi che non possono essere attribuiti alla sua attività professionale nè commerciale nè autonoma.)
Informativa sul diritto di recesso
Diritto di recesso
Il presente contratto può essere rescisso entro 1 mese senza obbligo di specificarne i motivi.
Il termine di revoca è di 1...
Se sei un consumatore puoi recedere dal contratto in conformità con quanto segue. Per Consumatore si intende qualsiasi persona fisica che agisce per scopi estranei alla propria attività commerciale, imprenditoriale, artigianale o professionale.
Informazioni sul diritto di recesso
Diritto legale di recesso
Hai il diritto di recedere dal presente contratto entro 14 giorni senza fornire alcuna motivazione.
Il periodo di recesso scade dopo 14 giorni dal giorno in cui tu o una terza parte, diversa dal vettore e da te indicata, acquisisce il possesso fisico dell'ultimo bene o dell'ultimo lotto o pezzo.
Per esercitare il diritto di recesso, compila e invia elettronicamente una dichiarazione esplicita sul nostro sito Web, alla voce “I miei acquisti” nella sezione “Mio account”. Ti comunicheremo senza indugio una conferma di ricezione di tale recesso su un supporto durevole (ad es. via e-mail).
Per rispettare il termine di recesso, è sufficiente inviare la comunicazione relativa all'esercizio del diritto di recesso prima della scadenza del periodo di recesso stesso.
Effetti del recesso
In caso di recesso dal presente contratto, ti rimborseremo tutti i pagamenti ricevuti, compresi i costi di spedizione (ad eccezione dei costi supplementari derivanti dalla tua eventuale scelta di un tipo di spedizione diverso dal tipo meno costoso di consegna standard da noi offerto).
Potremo effettuare una detrazione dal rimborso per la perdita di valore dei beni forniti, qualora tale perdita sia il risultato di una manipolazione non necessaria da parte tua.
Eseguiremo il rimborso senza indebito ritardo e non oltre 14 giorni dal giorno in cui saremo informati della tua decisione di recedere dal presente contratto.
Il rimborso sarà effettuato utilizzando lo stesso mezzo di pagamento da te usato per la transazione iniziale, salvo che tu non abbia espressamente concordato altrimenti; in ogni caso, non dovrai sostenere alcun costo quale conseguenza di tale rimborso.
Possiamo trattenere il rimborso finché non avremo ricevuto i beni oppure finché non avrai fornito la prova di averli rispediti, a seconda di quale condizione si verifichi per prima.
Dovrai rispedire i beni o consegnarli a moluna, Greven, Germany, senza indebito ritardo e, in ogni caso, entro 14 giorni dal giorno in cui ci hai comunicato la tua volontà di recedere dal presente contratto. Il termine è rispettato se rispedisci i beni prima della scadenza del periodo di 14 giorni. I costi diretti della restituzione dei beni saranno a tuo carico. Sei responsabile solo della diminuzione del valore dei beni risultante da una manipolazione diversa da quella necessaria per stabilire la natura, le caratteristiche e il funzionamento dei beni stessi.
Eccezioni al diritto di recesso
Il diritto di recesso non si applica a:
II. Kundeninformationen
Moluna GmbH
Engberdingdamm 27
48268 Greven
Deutschland
Telefon: 02571/5698933
E-Mail: abe@moluna.de
Wir sind nicht bereit und nicht verpflichtet, an Streitbeilegungsverfahren vor Verbraucherschlichtungsstellen teilzunehmen.
Die technischen Schritte zum Vertragsschluss, der Vertragsschluss selbst und die Korrekturmöglichkeiten erfolgen nach Maßgabe der Regelungen "Zustandekommen des Vertrages" unserer Allgemeinen Geschäftsbedingungen (Teil I.).
3.1. Vertragssprache ist deutsch .
3.2. Der vollständige Vertragstext wird von uns nicht gespeichert. Vor Absenden der Bestellung können die Vertragsdaten über die Druckfunktion des Browsers ausgedruckt oder elektronisch gesichert werden. Nach Zugang der Bestellung bei uns werden die Bestelldaten, die gesetzlich vorgeschriebenen Informationen bei Fernabsatzverträgen und die Allgemeinen Geschäftsbedingungen nochmals per E-Mail an Sie übersandt.
Die wesentlichen Merkmale der Ware und/oder Dienstleistung finden sich im jeweiligen Angebot.
5.1. Die in den jeweiligen Angeboten angeführten Preise sowie die Versandkosten stellen Gesamtpreise dar. Sie beinhalten alle Preisbestandteile einschließlich aller anfallenden Steuern.
5.2. Die anfallenden Versandkosten sind nicht im Kaufpreis enthalten. Sie sind über eine entsprechend bezeichnete Schaltfläche auf unserer Internetpräsenz oder im jeweiligen Angebot aufrufbar, werden im Laufe des Bestellvorganges gesondert ausgewiesen und sind von Ihnen zusätzlich zu tragen, soweit nicht die versandkostenfreie Lieferung zugesagt ist.
5.3. Die Ihnen zur Verfügung stehenden Zahlungsarten sind unter einer entsprechend bezeichneten Schaltfläche auf unserer Internetpräsenz oder im jeweiligen Angebot ausgewiesen.
5.4. Soweit bei den einzelnen Zahlungsarten nicht anders angegeben, sind die Zahlungsansprüche aus dem geschlossenen Vertrag sofort zur Zahlung fällig.
6.1. Die Lieferbedingungen, der Liefertermin sowie gegebenenfalls bestehende Lieferbeschränkungen finden sich unter einer entsprechend bezeichneten Schaltfläche auf unserer Internetpräsenz oder im jeweiligen Angebot.
Soweit im jeweiligen Angebot oder unter der entsprechend bezeichneten Schaltfläche keine andere Frist angegeben ist, erfolgt die Lieferung der Ware innerhalb von 3-5 Tagen nach Vertragsschluss (bei vereinbarter Vorauszahlung jedoch erst nach dem Zeitpunkt Ihrer Zahlungsanweisung).
6.2. Soweit Sie Verbraucher sind ist gesetzlich geregelt, dass die Gefahr des zufälligen Untergangs und der zufälligen Verschlechterung der verkauften Sache während der Versendung erst mit der Übergabe der Ware an Sie übergeht, unabhängig davon, ob die Versendung versichert oder unversichert erfolgt. Dies gilt nicht, wenn Sie eigenständig ein nicht vom Unternehmer benanntes Transportunternehmen oder eine sonst zur Ausführung der Versendung bestimmte Person beauftragt haben.
Sind Sie Unternehmer, erfolgt die Lieferung und Versendung auf Ihre Gefahr.
Die Mängelhaftung richtet sich nach der Regelung "Gewährleistung" in unseren Allgemeinen Geschäftsbedingungen (Teil I).
letzte Aktualisierung: 23.10.2019
| Quantità dell'ordine | Da 26 a 60 giorni lavorativi | Da 26 a 60 giorni lavorativi |
|---|---|---|
| Primo articolo | EUR 48.99 | EUR 48.99 |
I tempi di consegna sono stabiliti dai venditori e variano in base al corriere e al paese. Gli ordini che devono attraversare una dogana possono subire ritardi e spetta agli acquirenti pagare eventuali tariffe o dazi associati. I venditori possono contattarti in merito ad addebiti aggiuntivi dovuti a eventuali maggiorazioni dei costi di spedizione dei tuoi articoli.